# Guardian Pharmacy Services Inc. (GRDN) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Pharmaceuticals. Price $40.77, market value $2.6 billion.

## Valuation
- **P/E (trailing): 39.2×**. Guardian Pharmacy Services Inc. trades at 39.2× trailing earnings. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 28.5×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 1.8×**. Each dollar of revenue is priced at 1.8×.
- **Price / book: 10.5×**. The shares trade at 10.5× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **EV / EBITDA: 23.1×**. Enterprise value is 23.1× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Earnings yield: 2.6%**. The inverse of the P/E: 2.6% of the price is earned each year.

## Profitability
- **Gross margin: 21.6%**. Guardian Pharmacy Services Inc. keeps 21.6% of revenue after the direct cost of what it sells, a thin margin typical of retail, distribution and commodity businesses.
- **Operating margin: 5.8%**. 5.8% of revenue is left after running the business.
- **Net margin: 3.4%**. 3.4% of each dollar of sales reaches the bottom line.
- **Return on equity: 22.6%**. 22.6% on shareholders' equity is excellent if it is not driven by leverage; sustained above 20% usually signals a competitive advantage.
- **Return on invested capital: 44.3%**. Return on all capital, debt included, is 44.3%: comfortably above what that capital costs.
- **Return on assets: 16.0%**. Each dollar of assets produces 16.0% of profit.

## Growth
- **Revenue growth (1 yr): 17.9%**. Revenue grew 17.9% over the last year.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: net cash**. Guardian Pharmacy Services Inc. holds more cash than debt.
- **Altman Z-score: 12.79**. A Z-score of 12.79 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 6/9**. 6 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. Guardian Pharmacy Services Inc. does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): 43.2%** (YTD 35.5%, 3-mo 0.7%). The shares are up 43.2% over twelve months including dividends.
- **From 52-week high: -13.3%** (76.2% above the low). Trading 13% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 60**. An RSI of 60 is neutral.
- **Beta (1 yr): 0.80** (volatility 41%). Beta of 0.80 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=GRDN · Page: https://foliofundamentals.com/stocks/grdn

Not investment advice.